Header Logo

Connection

Gabriel Pardo to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications Gabriel Pardo has written about Randomized Controlled Trials as Topic.
Gabriel Pardo
Connection Strength
0.053
Randomized Controlled Trials as Topic
  1. Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis. Mult Scler Relat Disord. 2026 Jan; 105:106886.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.